, Volume 158, Issue 1, pp 91–100 | Cite as

The effect of intraalveolar fluid on lung bacterial clearance

  • G. D. Harris
  • D. E. Woods
  • R. Fine
  • W. G. Johanson


Appropriate animal models of lung bacterial clearance are difficult to establish in part because our current understanding of the pathogenesis of human pneumonia is imprecise. If all available models produced similar data their relevance to human infection would be strengthened. To assess consistency between two such models, we studied the effects of pulmonary edema and intratracheally injected protein on the pulmonary clearance of either aerosolized or intratracheally injectedStaphylococcus aureus orStreptococcus pneumoniae. Intraalveolar fluid, whether produced by increasing pulmonary capillary permeability or by intratracheal inoculation of bacteria, impaired lung bacterial clearance. This impairment varied with the organism employed. Proteinaceous intraalveolar fluid does not impair clearance by supporting bacterial multiplication and may enhance clearance of some organisms. Our results suggest that animal models of human lung infection are not easily constructed, remain problematic, and, at best, are only valid for the specific conditions of the model.

Key words

Bacterial clearance Pulmonary infection Pulmonary edema 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ansfield MJ, Woods DE, Johanson WG Jr (1977) Lung bacterial clearance in murine pneumococcal pneumonia. Infect Immun 17:195–204PubMedGoogle Scholar
  2. 2.
    Berendt RF (1978) Relationship of method of administration to respiratory virulence ofKlebsiella pneumoniae for mice and squirrel monkeys. Infect Immun 20:581–583PubMedGoogle Scholar
  3. 3.
    Ehlenberger AG, Nussenzweig V (1977) The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med 145:357–371PubMedCrossRefGoogle Scholar
  4. 4.
    Flint FV (1954) Factor of infection on heart failure. Br Med J 2:1018–1022PubMedGoogle Scholar
  5. 5.
    Goldstein E, Lippert W, Warshauer D (1974) Pulmonary alveolar macrophage: Defender against bacterial infection of the lung. J Clin Invest 54:519–528PubMedGoogle Scholar
  6. 6.
    Green GM, Kass EH (1964) The role of the alveolar macrophage in the clearance of bacteria from the lung. J Exp Med 119:167–176PubMedCrossRefGoogle Scholar
  7. 7.
    Gross GN, Rehm SR, Pierce AK (1978) The effect of complement depletion on lung clearance of bacteria. J Clin Invest 62:373–378PubMedGoogle Scholar
  8. 8.
    Hof DG, Peterson PK, Repine JE, Hoidal JR (1980) Phagocytosis by human alveolar macrophages and neutrophils: Qualitative differences in the opsonic requirements for uptake ofStaphylococcus aureus andStreptococcus pneumoniae in vitro. Am Rev Respir Dis 121:65–72PubMedGoogle Scholar
  9. 9.
    Jakab GJ (1976) Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms. Infect Immun 14:389–398PubMedGoogle Scholar
  10. 10.
    Jakab GJ, Green GM (1974) Pulmonary defense mechanisms in consolidated and nonconsolidated regions of lungs infected with Sendai virus. J Infect Dis 129:363–367PubMedGoogle Scholar
  11. 11.
    Jay SJ, Johanson WG Jr, Pierce AK (1974) Bacterial growth in vivo: An important determinant of the pulmonary clearance ofDiplococcus pneumoniae in rats. J Clin Invest 53:1320–1325CrossRefGoogle Scholar
  12. 12.
    LaForce FM, Mullane JF, Boehme RF, Kelly WJ, Huber GL (1973) The effect of pulmonary edema on antibacterial defenses of the lung. J Lab Clin Med 82:634–648PubMedGoogle Scholar
  13. 13.
    Laurenzi GA, Berman L, First M, Kass EH (1964) A quantitative study of the deposition and clearance of bacteria in the murine lung. J Clin Invest 43:759–768PubMedGoogle Scholar
  14. 14.
    McVay LV, Sprung DH, Stein DN (1954) Antibiotic prophylaxis in chronic congestive heart failure. Am J. Med Sci 226:491–503CrossRefGoogle Scholar
  15. 15.
    Pierce AK, Reynolds RC, Harris GD (1977) Leukocytic response to inhaled bacteria. Am Rev Respir Dis 116:679–684PubMedGoogle Scholar
  16. 16.
    Raphael SS (1976) Lynch’s Medical Laboratory Technology. WB Saunders, Philadelphia, p 228Google Scholar
  17. 17.
    Rehm SR, Gross GN, Hart DA, Pierce AK (1979) Animal model of neutropenia suitable for the study of dual phagocyte systems. Infect Immun 25:229–303Google Scholar
  18. 18.
    Van Oss CJ (1975) Phagocytic engulfment and cell adhesiveness as cellular surface phenomena. Marcel Dekker Inc, New York Basel, pp 29–30Google Scholar
  19. 19.
    Wood WB Jr, Smith MR, Watson B (1946) Studies on the mechanism of recovery in pneumococcal pneumonia. IV. The mechanism of phagocytosis on the absence of antibody. J Exp Med 84:387–402CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • G. D. Harris
    • 1
    • 2
  • D. E. Woods
    • 1
    • 2
  • R. Fine
    • 1
    • 2
  • W. G. Johanson
    • 1
    • 2
  1. 1.Departments of Medicine and MicrobiologyThe University of Texas Health Science Center at San AntonioSan Antonio
  2. 2.the Audie L. Murphy Memorial Medical CenterSan AntonioUSA

Personalised recommendations